Transactions & Cases Detail
MDS completes US$650 million sale of MDS Analytical Technologies' business to affiliates of Danaher Corp
January 29, 2010
Pharmaceutical / Bio Life Sciences
650 Million USD
The Company also announced that it intends to sell its MDS Pharma Services business, a leading provider of innovative drug discovery and early-stage development solutions for pharmaceutical and biotechnology companies. Upon completion of these transactions, the Company would be focused solely on its MDS Nordion business, which is a leading provider of medical isotopes for molecular and diagnostic imaging, radiotherapeutics and sterilization technologies.
On January 29, 2010, affiliates of Danaher Corporation acquired MDS Analytical Technologies’ business.
MDS Inc., headquartered in Ottawa, Ontario, is a leading provider of products and services to the global life sciences markets.
Danaher, headquartered in Washington, DC, concentrates in the fields of design, manufacture, and marketing of industrial and consumer products.
McCarthy Tétrault LLP represented MDS, as seller, with a team led by Douglas Cannon.